The Effect of a Newly Designed Presurgical Orthopedic Appliance

Sponsor
University of Baghdad (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05535530
Collaborator
(none)
30
1
2
20
1.5

Study Details

Study Description

Brief Summary

A randomized clinical trial to compare the effectiveness of newly designed active type of presurgical orthopedic appliances on maxillary arch dimensions in infants with bilateral cleft lip and palate.

Condition or Disease Intervention/Treatment Phase
  • Device: Active PSIO
N/A

Detailed Description

It is a multicenter randomized clinical trial with two parallel arms. The patients will be randomly divided into two groups, group one: a passive orthopedic appliance will be used, and group two a new designed active orthopedic appliance will be used. Impressions will be taken before starting the treatment (T1) and at the end of treatment (T2) three months later. The effectiveness of the two appliances will be assessed and measured on digital models of the maxillary arch before and after the treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of a Newly Designed Presurgical Orthopedic Appliance on Maxillary Arch Dimensions in Infants With Bilateral Cleft Lip and Palate: Randomized Clinical Trial
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Aug 15, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

Passive PSIO will be used

Experimental: Experimental

Active PSIO will be used

Device: Active PSIO
new designed active orthopedic appliance will be used. Impressions will be taken before starting the treatment (T1) and at the end of treatment (T2) three months later. The effectiveness of the two appliances will be assessed and measured on digital models of the maxillary arch before and after the treatment.

Outcome Measures

Primary Outcome Measures

  1. Arch dimension (experimental group and control group) [T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)]

    Evaluation of the efficiency of a newly designed presurgical infant orthopedic for bilateral cleft lip and palate patients by measuring the maxillary arch dimension at the beginning and end of treatment in both experimental and control group.

Secondary Outcome Measures

  1. Parents Perception and experience [T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)]

    The perception and experience of parents of children with cleft lip and palate concerning the use presurgical infant orthopedics using a questionnaire-based cross sectional survey. The assessment of mothers' perception and experience regarding PSIO will be executed using 16 validated preformed questions. The onset of the sign of the positive correction of the cleft segments will be recorded accordingly. In addition, PSIO management, including the removable appliance's hygiene maintenance, was also assessed.

  2. Linear measurement (experimental group and control group) [T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)]

    The linear measurements of arch dimensions in millimeter before and after treatment with the new presurgical infant orthopedic within the cleft patients in both experimental and control group. Linear measurements for maxillary arch assessments in millimeters: Antero-posterior arch length (I-RTLT) Posterior arch width (RT-LT) Alveolar cleft widths (AP); Right: RP-RA and left: LP-LA Mid-palatal arch width (RM-LM)

  3. Angular measurement (experimental group and control group) [T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)]

    The angular measurements of arch dimensions before and after treatment with the new presurgical infant orthopedic within the cleft patients in both experimental and control group. Angular measurements for maxillary arch assessments in degrees: Vertical deviation amount of premaxilla Horizontal deviation amount of premaxilla

  4. Vertical measurement (experimental group and control group) [T1 before starting any treatment and T2 After treatment before surgical repair (average 3 months)]

    The vertical measurements of arch dimensions in millimeter before and after treatment with the new presurgical infant orthopedic within the cleft patients in both experimental and control group. Vertical measurements for maxillary arch assessments in millimeters: The height of alveolar bone at RM The height of alveolar bone at LM

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Days to 2 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
    1. Healthy new born infants with complete bilateral cleft lip, alveolus and palate.
  1. Non-syndromic. 3. Non-operated cases.
Exclusion Criteria:
    1. Infants with systemic syndromes. 2.Facial deformities.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mushreq Abed Baghdad Al-Rusafa Iraq 01110

Sponsors and Collaborators

  • University of Baghdad

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mushriq F. Abid, Professor, University of Baghdad
ClinicalTrials.gov Identifier:
NCT05535530
Other Study ID Numbers:
  • 262421
First Posted:
Sep 10, 2022
Last Update Posted:
Sep 10, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Mushriq F. Abid, Professor, University of Baghdad
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 10, 2022